Inhibikase Therapeutics logo
Inhibikase Therapeutics IKT
$ 3.15 -1.72%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Inhibikase Therapeutics EV/EBITDA Ratio 2011-2024 | IKT

Annual EV/EBITDA Ratio Inhibikase Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.25 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.25 1.25 1.25